Centers for Disease Control and Prevention Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application | RFA PS 15 00103CONT17

Opportunity Information: Apply for RFA PS 15 00103CONT17

The Centers for Disease Control and Prevention (CDC), within the U.S. Department of Health and Human Services (HHS), issued a grant opportunity titled "Centers for Disease Control and Prevention Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application." This announcement is essentially a continuation notice rather than a new, open competition. It is designed for existing recipients to apply for ongoing funding and permission to continue work that was previously approved under the Positive Health Check Evaluation Trial effort. In practical terms, it signals that CDC intended to keep supporting an established portfolio of projects tied to evaluating the Positive Health Check intervention, with recipients submitting the required continuation materials for the FY2017 budget period.

The opportunity is identified by Funding Opportunity Number RFA PS 15 00103CONT17, which indicates it is a continuation tied back to an earlier program announcement (the "PS 15" family) rather than a brand-new solicitation. The Opportunity Category is listed as "Continuation" and the Funding Instrument Type is a "Cooperative Agreement." A cooperative agreement is different from a standard grant because it typically involves substantial federal involvement; that usually means CDC program staff may work closely with awardees on planning, implementation, evaluation approaches, performance monitoring, and other technical or administrative aspects of the project. The Funding Activity Category is "Health," and the CFDA number is 93.941, which is associated with HIV prevention activities, reinforcing that this continuation is situated in CDC's HIV prevention and care support landscape.

Eligibility is described broadly as "Others," with a note to consult the additional eligibility language in the full announcement text. That phrasing commonly appears in continuation actions because eligibility is often effectively limited to current awardees under the underlying cooperative agreement. In other words, while the top-line field does not list a specific applicant class (such as states, universities, or nonprofits), the intent of a noncompetitive continuation is typically that only organizations already funded under the original award can apply for continued support in the next budget period, assuming they remain in good standing and meet performance and reporting requirements.

Key administrative dates and basic scale indicators are also provided. The opportunity record shows a Creation Date of February 13, 2017, and an Original Closing Date of April 26, 2017, which would have been the deadline for continuation submissions for that fiscal year cycle. The Expected Awards figure is 10, suggesting CDC anticipated funding continuation actions for about ten existing projects or recipients under this effort for FY2017. The Award Ceiling is listed as 0, which usually indicates that a single maximum award amount is not specified in the summary record and that actual funding levels would be determined by the approved project plans, the recipient's continuation application, the availability of appropriations, and CDC's programmatic determinations for the budget period.

Overall, this solicitation is best understood as a FY2017 continuation mechanism for the Positive Health Check Evaluation Trial work, administered by CDC through cooperative agreements. It was not framed as a competitive opportunity to attract new applicants; instead, it served as the formal vehicle for CDC to review progress, receive updated work plans and budgets, and extend support to existing awardees engaged in evaluating the Positive Health Check intervention within the broader HIV prevention and care context.

• The Department of Health and Human Services, Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Centers for Disease Control and Prevention Positive Health Check Evaluation Trial Solicitation for FY2017 Noncompetitive Continuation Application" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.941.
• This funding opportunity was created on Feb 13, 2017.
• Applicants must submit their applications by Apr 26, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for RFA PS 15 00103CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: